Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 16, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that the Company's Board of Directors has elected Nelda Connors as a Director. Ms....
-
Dec 14, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the completion of a public offering of $2 billion aggregate principal amount of its...
-
Dec 10, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the pricing of a public offering of $2 billion aggregate principal amount of its senior...
-
Nov 23, 2009
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference, December 1-2. Ray Elliott,...
-
Nov 20, 2009Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets
Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S. Food and Drug...
-
Nov 10, 2009Company supports efforts of International Diabetes Federation to promote worldwide diabetes education and prevention
Boston Scientific Corporation (NYSE: BSX) today announced its official sponsorship of "World Diabetes Day" for the second year in a row. The...
-
Nov 9, 2009
Boston Scientific Corporation (NYSE: BSX) today announced its schedule of events at the 38th annual Global Congress for Minimally Invasive...
-
Nov 9, 2009COGNIS® CRT-D and TELIGEN® ICD are the world's smallest and thinnest high-energy devices
Boston Scientific Corporation (NYSE: BSX) today announced the launch of its COGNIS® cardiac resynchronization therapy defibrillator (CRT-D) and...
-
Nov 6, 2009Company updates third quarter financial results and full-year 2009 guidance
Boston Scientific Corporation (NYSE: BSX) today announced that it has reached an agreement in principle with the U.S. Department of Justice (DOJ)...
-
Nov 2, 2009Third-generation drug-eluting stent now available in CE Mark countries
Boston Scientific Corporation (NYSE: BSX) today announced it has received CE Mark for its PROMUS® Element™ Everolimus-Eluting Coronary Stent...
-
Oct 19, 2009
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2009, as well as guidance for...
-
Oct 9, 2009
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30,...
-
Oct 6, 2009Three models of stenting system now available for palliative treatment of malignant common bile duct strictures
Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
-
Oct 5, 2009
Boston Scientific Corporation (NYSE: BSX) today announced its exclusive sponsorship and first enrollments of the MADIT-RIT clinical trial. This new...
-
Sep 29, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the settlement of more than a dozen lawsuits involving Johnson & Johnson, including the...
-
Sep 25, 2009
Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from the HORIZONS-AMI trial. The trial,...
-
Sep 23, 2009Results support benefits of paclitaxel-eluting stents in diabetic patients
Boston Scientific Corporation (NYSE: BSX) today welcomed one-year data from the SPIRIT IV clinical trial comparing the XIENCE...
-
Sep 22, 2009Three-year TAXUS ATLAS results show safety and efficacy advantages for Boston Scientific TAXUS Liberte Stent
Boston Scientific Corporation (NYSE: BSX) today announced comprehensive data from the TAXUS ATLAS clinical program, a series of...
-
Sep 21, 2009Both drug-eluting stents performed well in diabetic patients
Boston Scientific Corporation (NYSE: BSX) today welcomed three-year results from the SPIRIT III clinical trial, which continue...
-
Sep 21, 2009
Boston Scientific Corporation (NYSE: BSX) today announced release of its CE-Marked, next-generation iLab System Software for the iLab® Ultrasound...
-
Sep 18, 2009PLATINUM clinical program to support FDA approval of PROMUS® Element™ Stent
Boston Scientific Corporation (NYSE: BSX) today announced the completion of patient enrollment in the workhorse portion of its PLATINUM clinical...
-
Sep 16, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Cardiovascular Research...
-
Sep 14, 2009Boston Scientific's Urology/Gynecology Business Forms Marketing Alliance with Bladder Health NetworkAgreement promotes access to testing solutions for female urinary incontinence
Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a co-marketing agreement with Bladder Health Network, a...
-
Sep 10, 2009
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Conference, September 14-15. Ray...
-
Sep 4, 2009
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Thomas Weisel Partners 2009 Health Care Conference, September 9 - 11....
-
Sep 2, 2009
Boston Scientific Corporation (NYSE: BSX) today announced two-year data from its SYNTAX clinical trial comparing percutaneous...
-
Sep 1, 2009
Boston Scientific Corporation (NYSE: BSX) today announced long-term data from the Prevention of Sudden Cardiac Death II registry...
-
Sep 1, 2009Results of landmark heart failure trial published by New England Journal of Medicine and presented at ESC
Boston Scientific Corporation (NYSE: BSX) today announced final results from the landmark MADIT-CRT trial, which were published by the...
-
Aug 31, 2009Dr. Ken Stein to join CRM group
Boston Scientific Corporation (NYSE: BSX) today announced that Ken Stein, M.D., FACC, will join the Company as Senior Vice President and Associate...
-
Aug 27, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements for the European...
-
Aug 26, 2009
The statement below is from Pete Nicholas, Chairman of the Board of Boston Scientific Corporation, on behalf of the Company, its employees and its Board of...
-
Aug 24, 2009
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing final results from the landmark MADIT-CRT trial on Tuesday,...
-
Aug 3, 2009
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the BMO Capital Markets 9(th) Annual Focus on Health Care Conference, August 5.
-
Jul 29, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that the Company's Board of Directors has elected Katharine T. Bartlett and Bruce L....
-
Jul 20, 2009
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the second quarter ended June 30, 2009, as well as guidance for net...
-
Jul 16, 2009Longest available drug-eluting stent strengthens Company's broad portfolio
Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its...
-
Jul 13, 2009
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark for its LATITUDE® Patient Management system. The LATITUDE system remotely...
-
Jul 7, 2009
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2009...
-
Jun 25, 2009
Boston Scientific Corporation (NYSE: BSX) announced today that President and Chief Executive Officer (CEO) Jim Tobin will retire from the Company,...
-
Jun 23, 2009
Landmark trial shows Boston Scientific CRT-Ds slow the progression of heart failure in asymptomatic and mildly symptomatic patients NATICK, Mass., June 23 /PRNewswire-FirstCall/ -- Boston...
-
Jun 18, 2009
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Wachovia 19th Annual Mid-Year Equity Conference, June 23 - 24. Jim...
-
Jun 15, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that results from nine studies involving the Company's Urology/Gynecology products will...
-
May 28, 2009
Studies to be presented on safety and efficacy of SpyGlass System for diagnostic and therapeutic procedures throughout pancreatico-biliary system NATICK, Mass., May 28 /PRNewswire-FirstCall/ --...
-
May 28, 2009
SpyGlass® Direct Visualization System can now be used for diagnostic and therapeutic procedures for pancreatic disease NATICK, Mass., May 28 /PRNewswire-FirstCall/ -- Boston Scientific...
-
May 27, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that Ursula Burns and Kristina Johnson have resigned from the Company's Board of Directors...
-
May 27, 2009
Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its...
-
May 26, 2009
Risk of death at five years is lower for aneurysm patients treated with coil embolization compared to surgical clipping NATICK, Mass., May 26 /PRNewswire-FirstCall/ -- Boston Scientific...
-
May 20, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the start of patient enrollment in the ORION clinical trial, which is designed to evaluate...
-
May 20, 2009
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of economic and quality of life outcomes,...
-
May 19, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that Fitch Ratings has raised the Company's rating outlook to positive from stable, while...
-
May 19, 2009
Boston Scientific Corporation (NYSE: BSX) today announced positive outcomes from a substudy of patients with left main coronary...
-
May 19, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the launch of the...
-
May 19, 2009
Online tools will help physicians determine treatment strategies NATICK, Mass. and BARCELONA, Spain, May 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today welcomed the...
-
May 15, 2009
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray PCR Post-Op Summit in London. Jim Tobin, President and...
-
May 15, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's events and news announcements at the annual EuroPCR...
-
May 14, 2009
Boston Scientific Corporation (NYSE: BSX) today announced data from its ALTITUDE Clinical Science program that show real-word survival rates for...
-
May 14, 2009
Analysis indicates that one life is now saved for every six patients who receive an ICD NATICK, Mass., May 14 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced...
-
May 13, 2009
Boston Scientific Corporation (NYSE: BSX) today announced that it has agreed to donate Cardiac Rhythm Management (CRM) devices, including...
-
May 12, 2009
Company's new lead system reduces implant size of the world's smallest and thinnest high-energy devices NATICK, Mass., May 12 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today...
-
May 11, 2009
Boston Scientific Corporation today welcomed the publication of an article...
-
May 11, 2009
Boston Scientific Corporation today announced the schedule of the Company's major events and news announcements at the 30th Annual Scientific...
-
May 6, 2009
Data from landmark trial provide important insight for physicians in treating heart attack patients NATICK, Mass., May 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today welcomed the...
-
May 5, 2009
Boston Scientific Corporation is scheduled to participate in the upcoming Bank of America and Merrill Lynch Health Care Conference. Jim Tobin,...
-
Apr 20, 2009
Boston Scientific Corporation today announced financial results for the first quarter ended March 31, 2009, as well as guidance for net sales and...
-
Apr 15, 2009
Boston Scientific today announced special items that will reduce its GAAP earnings for the first quarter. The Company plans to release its first...
-
Apr 6, 2009
Boston Scientific Corporation will webcast its conference call discussing financial results for the first quarter ended March 31, 2009 on Tuesday,...
-
Mar 31, 2009
Boston Scientific Corporation announced today that the Court of Appeals for the Federal Circuit issued a decision in the Company's stent...
-
Mar 31, 2009
Boston Scientific Corporation today welcomed passage of the National Pain Care Policy Act of 2009 by the U.S. House of Representatives. The...
-
Mar 29, 2009Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent PlatformsThree-year results and two-year pooled analysis presented at ACC demonstrate continued positive outcomes for both PROMUS® and TAXUS® Stents
Boston Scientific Corporation today welcomed three-year results from the SPIRIT II Clinical Trial and a pooled meta-analysis of...
-
Mar 28, 2009
Boston Scientific Corporation today announced results from an analysis of economic and quality of life outcomes, based on...
-
Mar 26, 2009
Boston Scientific Corporation today announced the schedule of the Company's major events and news announcements at the 58th Annual Scientific...
-
Mar 25, 2009
Boston Scientific Corporation today announced that Standard and Poor's Ratings Services has raised the Company's rating outlook to positive from...
-
Mar 19, 2009
Boston Scientific Corporation today announced the launch of its iCross™ Coronary Imaging Catheter, a product designed to improve the...
-
Mar 12, 2009
Boston Scientific Corporation today announced that Moody's Investors Service has raised the Company's rating outlook to stable from negative. In...
-
Mar 10, 2009
Boston Scientific Corporation is scheduled to participate in the upcoming Cowen and Company 29th Annual Health Care Conference. Jim Tobin, Chief...
-
Mar 4, 2009
Boston Scientific Corporation today welcomed approval by the U.S. House of Representative's Energy and Commerce Committee of the National Pain Care...
-
Mar 3, 2009
Boston Scientific Corporation today announced the launch of its TAXUS®...
-
Mar 2, 2009
Boston Scientific Corporation today announced that the Company's Board of Directors has elected John E. Sununu...
-
Feb 26, 2009
Boston Scientific Corporation today announced updated financial results for the fourth quarter ended December 31, 2008. Subsequent to the release...
-
Feb 18, 2009
Data show comparable safety for complex patients treated with TAXUS® Express2™ Stents and bypass surgery NATICK, Mass., Feb. 18 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today...
-
Feb 5, 2009
Journal of American College of Cardiology publishes positive ATLAS clinical data NATICK, Mass., Feb. 5 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that it has submitted...
-
Feb 3, 2009
PLATINUM clinical program to evaluate PROMUS™ Element™ Platinum Chromium Stent NATICK, Mass., Feb. 3 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced the beginning of...
-
Jan 28, 2009
Q4 adjusted results in line with expectations; Company well positioned for 2009 and beyond Company records $2.7 billion goodwill impairment charge NATICK, Mass., Jan. 28 /PRNewswire-FirstCall/ --...
-
Jan 28, 2009
Boston Scientific Corporation announced today that it has received approval from the...
-
Jan 27, 2009
Agreement stops all litigation in interventional cardiology and endovascular repair NATICK, Mass., Jan. 27 /PRNewswire-FirstCall/ -- Boston Scientific Corporation and Medtronic, Inc. today...
-
Jan 20, 2009
Boston Scientific Corporation today announced it has been awarded a contract by the U.S. Department of Veterans Affairs (VA) for a full line of the...
-
Jan 15, 2009
Boston Scientific Corporation today announced a decision by the Court of Appeals for the Federal Circuit. The case involves a Boston Scientific...
-
Jan 13, 2009
Boston Scientific Corporation will webcast its conference call discussing financial results for the fourth quarter and the year ended December 31,...
-
Jan 7, 2009
Boston Scientific Corporation is scheduled to participate in the upcoming JP Morgan Health Care Conference in San Francisco. Jim Tobin, Chief...
-
Jan 6, 2009
Acquisition demonstrates Company's commitment to innovation in drug-eluting stent technology NATICK, Mass., Jan. 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that it...
-
Dec 18, 2008
Boston Scientific Corporation today announced enrollment of the first patient...
-
Dec 15, 2008First low-profile, pre-mounted stent approved specifically for use in renal arteries
Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved the Express® SD Renal Monorail®...
-
Nov 24, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference, which is being held December 2 -...
-
Nov 10, 2008New design provides more options for treating patients with complex lesions
Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration to market its...
-
Oct 29, 2008
Boston Scientific Corporation (NYSE: BSX) today welcomed passage of legislation to help active members of the U.S. armed forces and service...
-
Oct 27, 2008Confirms clinical value and cost-effectiveness of spinal cord stimulation
Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the U.K.'s National Institute for Health and Clinical Excellence (NICE)...
-
Oct 23, 2008Leading carotid stent in Europe and other international markets now available in the United States
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved its Carotid WALLSTENT®...
-
Oct 21, 2008
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2008, as well as guidance for...
-
Oct 15, 2008Landmark trial provides new insight for physicians
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of the HORIZONS AMI trial. The HORIZONS AMI...
-
Oct 15, 2008
Boston Scientific Corporation (NYSE: BSX) today announced positive one-year results from the Intercontinental and European launch...